Literature DB >> 18442857

Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years.

C M Sonnenberg1, D J H Deeg, H C Comijs, W van Tilburg, A T F Beekman.   

Abstract

BACKGROUND: In the past 15 years, antidepressant use in adults has increased, mainly due to a rise in SSRI-use. The question is if this is true for older adults as well.
METHODS: Data from the Longitudinal Aging Study Amsterdam were used to investigate trends in antidepressant use from 1992 through 2002 in a population-based sample aged 65-85 years.
RESULTS: Antidepressant use increased from 2% to 6%. In the group with major depressive disorder, treatment with antidepressants showed an increase from 15% to 30%. This increase was larger in the older-old than in the younger old. Also, the increase was mainly due to a rise in SSRI-use. Daily TCA-dosages often were too low; dosages of the other antidepressants seemed to be sufficient. However, rates of depression remained stable, in the treated as well as in the untreated group. LIMITATIONS: Non-response was associated with depression, the indication for prescription of antidepressants was not known, and serum concentrations of antidepressants were not available.
CONCLUSIONS: Antidepressant use in older people increased over the past 15 years, mainly due to a rise in SSRI-use. Daily dosages of antidepressants had become more adequate. Still only a minority of the more severely depressed used antidepressants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442857     DOI: 10.1016/j.jad.2008.03.009

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study.

Authors:  Raymond Noordam; Nikkie Aarts; Katia M Verhamme; Miriam C M Sturkenboom; Bruno H Stricker; Loes E Visser
Journal:  Eur J Clin Pharmacol       Date:  2015-01-06       Impact factor: 2.953

2.  Under-treatment of depression in older persons.

Authors:  Lisa C Barry; Janet J Abou; Arthur A Simen; Thomas M Gill
Journal:  J Affect Disord       Date:  2011-10-26       Impact factor: 4.839

3.  Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life.

Authors:  M Rondanelli; A Giacosa; A Opizzi; C Pelucchi; C La Vecchia; G Montorfano; M Negroni; B Berra; P Politi; A M Rizzo
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

Review 4.  Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.

Authors:  Jenny T Wang; Benson Hoffman; James A Blumenthal
Journal:  Expert Opin Pharmacother       Date:  2010-08-17       Impact factor: 3.889

Review 5.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

6.  Age-related response to redeemed antidepressants measured by completed suicide in older adults: a nationwide cohort study.

Authors:  Annette Erlangsen; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 7.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

Review 8.  Cognitive impairment in depression: recent advances and novel treatments.

Authors:  Giulia Perini; Matteo Cotta Ramusino; Elena Sinforiani; Sara Bernini; Roberto Petrachi; Alfredo Costa
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-10       Impact factor: 2.570

9.  Diet and companionship modulate pain via a serotonergic mechanism.

Authors:  Huy Tran; Varun Sagi; Sarita Jarrett; Elise F Palzer; Rajendra D Badgaiyan; Kalpna Gupta
Journal:  Sci Rep       Date:  2021-02-01       Impact factor: 4.379

10.  Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system.

Authors:  Katja Weckmann; Michael J Deery; Julie A Howard; Renata Feret; John M Asara; Frederik Dethloff; Michaela D Filiou; Jamie Iannace; Christiana Labermaier; Giuseppina Maccarrone; Christian Webhofer; Larysa Teplytska; Kathryn Lilley; Marianne B Müller; Christoph W Turck
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.